中国中医科学院广安门医院,北京市西城区北线阁5号,100053,100053
rudu0226@163.com,(010)88001019
收稿:2022-03-08,
修回:2022-03-30,
纸质出版:2022-11-17
移动端阅览
.运用态靶辨治理论治疗特发性间质性肺病经验[J].中医杂志,2022,63(22):2110-2113.
WANG Wenjie,WANG Min,WANG Lei,et al.Experience in Treating Idiopathic Interstitial Pneumonia Using the Theory of “State Differentiation and Target Treatment”[J].Journal of Traditional Chinese Medicine,2022,63(22):2110-2113.
.运用态靶辨治理论治疗特发性间质性肺病经验[J].中医杂志,2022,63(22):2110-2113. DOI: 10.13288/j.11-2166/r.2022.22.003.
WANG Wenjie,WANG Min,WANG Lei,et al.Experience in Treating Idiopathic Interstitial Pneumonia Using the Theory of “State Differentiation and Target Treatment”[J].Journal of Traditional Chinese Medicine,2022,63(22):2110-2113. DOI: 10.13288/j.11-2166/r.2022.22.003.
仝小林院士提出“态靶辨治”的现代中医诊疗体系,并将其用于慢性疾病临床诊疗过程中。以“态靶辨治”理论为指导,结合临床经验与现代药理学研究成果,根据特发性间质性肺病(IIP)在不同病理阶段的影像学特点及临床表现,划分肺氲期、肺痹期、肺痿期三期,从虚、瘀、寒、浊、瘠五态认识IIP,并探讨各期各态下的IIP治疗原则及相应靶药。通过分期、分态治疗明确IIP的阶段性诊疗,进而优化IIP的临床诊疗方案。
It is known that academician TONG Xiaolin has proposed the theory of “state differentiation and target treatment”, and has used it in the clinical diagnosis and treatment of chronic diseases. Guided by this theory and the findings from clinical experience and modern pharmacological researches, idiopathic interstitial pneumonia (IIP) is initially categorized into three stages by different pathological imaging characteristics and clinical manifestations, including steamed lung stage, rheumatoid lung stage and flaccid lung stage, and it will be further understood from five states which are deficiency state, stasis state, cold state, turbidity state, and barren state. The treatment principle of IIP and the corresponding target drugs are then determined in relation to each stage and each state. By stage- and state-differentiated treatment, we are looking forward to clarifying the phased diagnosis and treatment of IIP and effectively optimizing the clinical diagnosis and treatment plan of IIP.
仝小林 . 态靶医学:中医未来发展之路 [J]. 中国中西医结合杂志 , 2021 , 41 ( 1 ): 16 - 18 .
何莉莎 , 顾成娟 , 王涵 , 等 . 态靶结合辨治代谢性高血压病 [J]. 中医杂志 , 2019 , 60 ( 16 ): 1423 - 1424,1427 .
张晓梅 , 姜良铎 , 尹婷 , 等 . 肺纤方治疗特发性肺间质纤维化临床研究 [J]. 北京中医药 , 2009 , 28 ( 4 ): 254 - 256 .
张晓雪 , 李国勤 , 李辉 , 等 . 芪术肺纤汤治疗特发性肺间质纤维化的生存质量评价 [J]. 中国中医药信息杂志 , 2013 , 20 ( 3 ): 80 - 81 .
龚年金 , 李少峰 , 刘良徛 . 治肺不远温思想在特发性肺间质纤维化治疗中的运用 [J]. 中华中医药杂志 , 2021 , 36 ( 2 ): 905 - 908 .
TRAVIS WD , COSTABEL U , HANSELL DM , et al . An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias [J]. Am J Respir Crit Care Med , 2013 , 188 ( 6 ): 733 - 748 .
TANIGUCHI H , KONDOH Y . Acute and subacute idiopathic interstitial pneumonias [J]. Respirology , 2016 , 21 ( 5 ): 810 - 820 .
陈冲 , 曾臣红 , 张斯琪 , 等 . 萆薢的研究进展 [J]. 中国中药杂志 , 2017 , 42 ( 18 ): 3488 - 3496 .
刘峻池 , 徐立 , 梁杨 , 等 . 蚕沙的药理研究及临床应用研究进展 [J]. 蚕学通讯 , 2010 , 30 ( 3 ): 14 - 17 .
王英豪 , 姚欣 , 邱颂平 , 等 . 破血化瘀药三棱莪术对大鼠肺纤维化干预作用的实验研究 [J]. 中国中医药科技 , 2011 , 18 ( 3 ): 188 - 189,220,176 .
黎金浓 , 何娅娜 , 周辉 , 等 . 基于网络药理学的黄芪抗肺纤维化机制预测与验证研究 [J]. 湖南中医药大学学报 , 2022 , 42 ( 2 ): 278 - 284 .
黄献欢 , 黄维 , 高兴华 . 红景天苷抑制大鼠肺纤维化机制研究 [J]. 临床和实验医学杂志 , 2018 , 17 ( 4 ): 343 - 345 .
张莉莉 , 王蕾 , 周毅徳 , 等 . 仝小林“慢病十态”之调态方略简析 [J]. 中医杂志 , 2021 , 62 ( 11 ): 934 - 938,942 .
CHEN M , CHEUNG FW , CHAN MH , et al . Protective roles of Cordyceps on lung fibrosis in cellular and rat models [J]. J Ethnopharmacol , 2012 , 143 ( 2 ): 448 - 454 .
陈冰 , 杨春艳 , 王雪兰 , 等 . 滇龙血竭分期干预对肺纤维化大鼠FIZZ1的影响 [J]. 中华中医药杂志 , 2020 , 35 ( 6 ): 3071 - 3074 .
MCMILLAN TR , MOORE BB , WEINBERG JB , et al . Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus [J]. Am J Respir Crit Care Med , 2008 , 177 ( 7 ): 771 - 780 .
罗金丽 , 顾成娟 , 赵林华 . 夜明砂、晚蚕砂、五灵脂调整肠道菌群经验:仝小林三味小方撷萃 [J]. 吉林中医药 , 2020 , 40 ( 1 ): 8 - 11 .
0
浏览量
0
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号